Davis Capital Management’s Indivior Pharmaceuticals INDV Stock Holding History

Davis Capital Management’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$287	Buy	+7	New	+$254	﹤0.01%	742

Other funds holding INDV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Davis Capital Management's INDV Position: Q2 2026 in Review

Davis Capital Management opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 7 shares worth $287. The stake represents ﹤0.01% of the portfolio and ranks #742 among its holdings.

49 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Davis Capital Management held 7 shares of Indivior Pharmaceuticals worth $287 as of Q2 2026.
Indivior Pharmaceuticals was a new Davis Capital Management position in Q2 2026.
Indivior Pharmaceuticals made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #742 holding.
49 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.